AI assistant
Greenyard NV — Interim / Quarterly Report 2018
Nov 20, 2018
3957_iss_2018-11-20_bbb5b95b-e171-46a4-a25a-7016fa122d3e.pdf
Interim / Quarterly Report
Open in viewerOpens in your device viewer
Greenyard announces results in line with earlier communications after a challenging first half year
Sint-Katelijne-Waver, Belgium, 20 November 2018 – Greenyard (Euronext Brussels: GREEN)
Key financials – first half accounting year ending 30 September 2018
- Sales. Greenyard suffered from exceptional weather circumstances over the whole of Europe. A persistent drought affected the growth of vegetables and fruit, with a high impact on the availability of the product and/or on market prices. Combined with earlier announced and continuing margin pressure in a number of Greenyard's key markets, this resulted in a net sales decline by 3,6% to € 1.982,8m (excluding discontinued operations). Without taking into account the FX effect (-0,2%), net sales declined by 3,2% versus last year.
- o Fresh: net sales declined by 3,5% to € 1.647,9m, mainly due to loss of volumes from competitive pressure and pricing impact as a result of the weather conditions.
- o Long Fresh: net sales declined by 4,1% to € 334,9m, primarily from the discontinuation of certain non-profitable contracts and delay of orders in Prepared, but also a temporary loss of sales due to the Listeria recall in Greenyard's Frozen division.
- REBITDA. In line with full year expectations as earlier communicated to the market, REBITDA for Greenyard fell with 39,9% to € 41,2m (excluding discontinued operations). The € 27,4m drop is mainly due to:
- o Fresh: REBITDA in Fresh fell by 49,0% to € 21,7m, given severe competitive pressure in Greenyard's key markets, causing inefficiencies, which was accelerated by the weather impact. Greenyard has taken measures to mitigate these factors, such as reorganisation of its footprint and organisational design. Greenyard expects a gradual improvement through a traditionally better second half year and stronger competitive position.
- o Long Fresh: REBITDA in Long Fresh for the first half year amounts to € 20,5m, representing a 20,3% drop. This decline is due to the negative impact of the exceptional weather conditions, causing shortages and lower cost absorption in the factories and to a lesser extent, the consequences of the Listeria recall.
- o Greenyard expects that its partnership strategy will bear fruit and will gradually improve profitability over the next few periods.
- Non-recurring items.
- o Listeria. Greenyard incurred a net non-recurring cost of € 22,6m and a recurring cost of € 3,5m related to the recall and destruction of frozen vegetables from its Hungarian facility and other related consequences thereof. The net nonrecurring costs and related assets and liabilities are determined based on a conservative estimate of the costs and insurance income. Greenyard updates its
REGULATED INFORMATION – INSIDE INFORMATION – 20 NOVEMBER 2018, 17.45pm CET
estimations for the total costs and expected insurance proceeds to an amount of € 28,0m, which is less than the initially communicated € 30,0m.
- o Impairment goodwill. Greenyard has decided to impair the goodwill of Greenyard as it was calculated at the time of completion of the business combination in 2015. This goodwill impairment amounts to € 29,2m for Long Fresh due to a potential delay in the expected profitability growth, caused by the recent events. The goodwill impairment does not affect the strategy, business or liquidity of Greenyard.
- The effective tax rate for the first half year amounts to -14,1%. The tax rate is driven by the reported loss and the use and reversal of deferred tax assets.
- The net result from continued operations amounts to a loss of € 68,1m. This result was negatively impacted by non-recurring items for a total amount of € -53,0m.
- Net financial debt. Net financial debt increased by € 98,3m to € 517,4m (including Horticulture), predominantly due to a lower profitability, non-recurring recall costs and the inventory build-up in the Long Fresh segment. This led to a leverage ratio of 4,4x end of September. Greenyard appreciates the full support it received from its relationship banks for the waiver on the covenant levels of September (2018) and March (2019). Greenyard is determined to structurally reduce the leverage over the coming periods. In order to strengthen its balance sheet, Greenyard has decided to act decisively by selling its Horticulture segment. Even after the sale of the Horticulture segment, Greenyard's focus remains on strengthening its balance sheet, now with strong emphasis on the improvement of its profitability and further internal growth.
- Discontinued operations.
- o The sale of the Horticulture segment to Straco will lead to total cash proceeds of € 120,0m. The proceeds of the sale of the Horticulture segment will be used to deleverage through the repayment of the € 150,0m retail bond that is due 5 July 2019, without affecting the existing credit facility or credit lines.
- o As the expected synergies with the Horticulture segment will no longer be realised within Greenyard, the sale entails an important goodwill impairment resulting from the valuation at fair value less cost to sell. The goodwill impairment does not affect the strategy, business or liquidity of Greenyard. Greenyard and Straco will examine how to further develop concepts for sustainably growing healthy and tasty vegetables and fruit, for a healthier future for all in the chain. Greenyard expects the closing of the transaction to occur before the end of this accounting year.
- Profit/loss for the period. A loss for the period from discontinued operations for an amount of € 44,9m results in a total loss for the period of € 113,0m.
-
CAPEX spent (including discontinued operations) for the first half year amounted to € 40,2m, and includes € 15,1m of payments from investments executed at the end of last accounting year. CAPEX for this year was materially reduced.
-
Greenyard now confidently looks towards the future with the current combination of the two segments: Fresh and Long Fresh. Greenyard has no further plans to sell any core activities. The announced measures for the optimisation of assets and the sale of non-core assets, as well as CAPEX savings and working capital optimisations are on track. In addition, Greenyard is deploying further strategic projects for a renewed focus of both segments, with a view to reinforcing the offer, improving net sales and margins and responding to the ever-changing demand of retailers and consumers. Greenyard will communicate more details as soon as more information is available.
- For AY 18/19, Greenyard maintains its guidance of REBITDA -25% versus last year, excluding currency impact.
- Interested parties are invited to listen to a live webcast by visiting the following link, or through the following dial-in: +32 2 342 07 47 (or toll-free number +32 800 11960), Passcode: 52454049#. The call will begin promptly at 6:30 p.m. (CET). An audio replay of the conference call will be available on Greenyard's Investor Relations webpage as of Wednesday 21 November.
Hein Deprez, CEO Greenyard:
"As communicated in August, the first half year of our accounting year 2018/2019 was challenging for Greenyard. Our results reflect the fierce competition and difficult market circumstances in our key markets. Consolidation in these markets puts pressure on all suppliers to find ways to deliver their products, even at low prices.
The current challenging market conditions have also led us to take certain decisive actions, such as the sale of our Horticulture segment, which was needed to strengthen our balance sheet again. We will use these proceeds to repay the retail bond that is due in July 2019. We continue to work hard to further strengthen our company and are fully focused on further internal growth.
Despite this hard market reality, we continue to believe in our strategy to form partnerships with our retailers by working closely and transparently together with them to rationalise the entire supply chain to the benefit of all: consumers, retailers, growers and Greenyard.
We already see good examples and stable growth for those retailers and Greenyard where we are able to build such partnership model. We will do that in the current combination of our Fresh and Long Fresh segments as a unique player in the market offering all categories in fruit and vegetables in all its forms: fresh, frozen and prepared. We are convinced we have the right people, heart, assets and strategy to defend our market position, grow our base and build these partnerships for the future."
Figure 1 – Key financials
| Key financials | H1 18/19 | H1 17/18 * | Difference |
|---|---|---|---|
| Sales continuing (€'000 000) | 1.982,8 | 2.056,6 | -3,6% |
| Sales discontinued (€'000 000) | 54,9 | 37,9 | 44,9% |
| REBITDA continuing (€'000 000) | 41,2 | 68,5 | -39,9% |
| REBITDA discontinued (€'000 000) | 7,6 | 4,9 | 56,1% |
| REBITDA-margin continuing % | 2,1% | 3,3% | |
| REBITDA-margin discontinued % | 13,9% | 12,9% | |
| Net result continuing (€'000 000) | -68,1 | 10,1 | -771,9% |
| Net result discontinued (€'000 000) | -44,9 | 2,3 | -2072,6% |
| EPS continuing (€) | -1,57 | 0,22 | -813,3% |
| EPS discontinued (€) | -1,07 | 0,05 | -2120,6% |
| NFD continuing (€'000 000) | 521,2 | 419,1 | 24,3% |
| NFD discontinued (€'000 000) | -3,8 | - | |
| Leverage | 4,4 | 2,8 |
* For NFD and leverage the figure reported is March 2018
Segment review
1 - Fresh
Figure 2 – Sales & REBITDA evolution
| Fresh | H1 18/19 | H1 17/18 | Difference |
|---|---|---|---|
| €'000 000 | €'000 000 | ||
| Sales | 1.647,9 | 1.707,3 | -3,5% |
| REBITDA | 21,7 | 42,6 | -49,0% |
| REBITDA-margin % | 1,3% | 2,5% |
Sales in Fresh declined with 3,5%. After FX correction of -0,1%, growth declined internally with a 3,2% drop.
Fresh felt competitive pressure in most of its core markets, particularly in Germany and Belgium. Sales decline was primarily due to exceptional weather conditions, a volume decline resulting from a combination of competitive pressure and shortages in certain Stock Keeping Units. Partnership model showing stable growth in all applicable markets.
REBITDA dropped by 49,0%, which represents a margin of 1,3% versus 2,5% last year (-120bps YoY). Key reason for the drop in REBITDA is the loss of volumes from competitive pressure, which entails loss of margin and increase in operational inefficiencies.
2 – Long Fresh
Figure 3 – Sales & REBITDA evolution
| Long Fresh | H1 18/19 | H1 17/18 | Difference |
|---|---|---|---|
| €'000 000 | €'000 000 | ||
| Sales | 334,9 | 349,4 | -4,1% |
| REBITDA | 20,5 | 25,7 | -20,3% |
| REBITDA-margin % | 6,1% | 7,4% |
In Long Fresh, net sales declined with 4,1%. Foreign currencies impacted sales negatively by 0,6%, largely driven by the Brazilian Real and the GBP. As such, internal sales showed a -3,5% evolution.
This sales decrease is mainly driven by the lower volumes sold immediately after the Listeria recall in Frozen and a number of delays in export orders and orders from some larger customers in Prepared, as well as the termination of some non-profitable contracts in the UK, Germany and France.
The Frozen division suffered from the Listeria recall given the loss of margin caused by lost sales volumes, and a loss of fixed cost absorption, due to the temporary closing of production in Hungary. REBITDA in the Prepared division was affected by lower sales volumes and lower sales prices (mainly in mushrooms), but continued to stand its ground and even performed slightly better than last year.
Non-recurring items
Figure 4 –Non-recurring items from operating activities
| Non-recurring items | H1 18/19 | H1 17/18 |
|---|---|---|
| €'000 | €'000 | |
| Reorganisation costs Fresh | - | -2.198 |
| Merger & acquisition project costs | - | -595 |
| Costs related to impact of Listeria | -22.604 | - |
| Waiver fee | -1.163 | - |
| Impairment goodwill Long Fresh | -29.172 | - |
| Other | -689 | -675 |
| Non-recurring expenses | -53.628 | -3.468 |
| Result on sale H-Pack & H-Fruit | - | 1.379 |
| Result on sale of assets | 586 | 12 |
| Non-recurring income | 586 | 1.391 |
| TOTAL | -53.041 | -2.076 |
Non-recurring items amounted to € 53,0m, compared to € 2,1m last year. The two main total nonrecurring items consist of costs related to the Listeria recall (€ 22,6m) and the goodwill impairment for Long Fresh (€ 29,2m).
Net Finance Income/ (Costs)
Figure 5 – Net finance income / (costs)
| Net finance income/cost (-) | H1 18/19 | H1 17/18 |
|---|---|---|
| €'000 | €'000 | |
| Interest expense | -15.844 | -14.330 |
| Interest income | 215 | 218 |
| Other finance result | 351 | -4.344 |
| TOTAL | -15.278 | -18.456 |
Net finance costs witnessed a decline of € 3,2m YoY due to lower exchange gains/losses and bank and other finance expenses, not offset by slightly higher interest expenses.
Income taxes & Net result
Figure 6 – Income taxes and net result
| Income taxes and net result | H1 18/19 €'000 |
H1 17/18 €'000 |
|---|---|---|
| CONTINUING OPERATIONS | ||
| Profit/loss (-) before income tax | -59.687 | 17.126 |
| Income tax expense (-)/income | -8.420 | -6.989 |
| Profit/loss (-) for the period from continuing operations | -68.107 | 10.137 |
| DISCONTINUED OPERATIONS | ||
| Profit/loss (-) for the period from discontinued operations | -44.850 | 2.274 |
| PROFIT/LOSS (-) FOR THE PERIOD | -112.957 | 12.411 |
| Attributable to: | ||
| The shareholders of the Group | -113.378 | 11.688 |
| Non-controlling interests | 421 | 722 |
The corporate tax charge of € 8,4m results in a tax rate of -14,1%. The tax rate is driven by the reported loss and the use and reversal of deferred tax assets.
Cash flow
Figure 7 – Cash flow statement for the 6 month period ending 30 September 2018
| Consolidated statement of cash flows | H1 18/19 €'000 |
H1 17/18 €'000 |
|---|---|---|
| CASH, CASH EQUIVALENTS AND BANK OVERDRAFTS, OPENING BALANCE | 57.432 | 112.735 |
| CASH FLOW FROM OPERATING ACTIVITIES (A) | -40.502 | 41.476 |
| EBIT Income taxes paid |
-87.974 -1.288 |
38.434 -2.674 |
| Adjustments Fair value adjustments biological assets Amortisation of intangible assets Depreciation and impairment of property, plant & equipment Impairment on goodwill Write-off on stock/trade receivables Increase/decrease (-) in provisions and employee benefit liabilities Gain (-)/loss on disposal of property, plant & equipment |
113.485 -476 10.049 26.577 76.185 6.078 -3.975 -771 |
30.653 -759 7.952 24.872 -1.437 661 -489 |
| Share of profit/loss (-) of equity accounted investments Increase (-) /decrease in working capital Increase (-)/decrease in inventories Increase (-)/decrease in trade and other receivables Increase/decrease (-) in trade and other payables |
-182 -64.726 -43.177 23.295 -44.843 |
-147 -24.937 -49.205 70.496 -46.229 |
| CASH FLOW FROM INVESTING ACTIVITIES (B) | -40.516 | -31.987 |
| Acquisitions (-) Acquisition of intangible assets and property, plant & equipment Acquisition of subsidiaries/ associates Disposals Disposal of intangible assets and property, plant & equipment |
-43.635 -40.161 -3.474 3.119 1.851 |
-35.175 -34.688 -487 3.188 1.172 |
| Disposal of subsidiaries/ associates | 1.268 | 2.017 |
| CASH FLOW FROM FINANCING ACTIVITIES (C) | 97.028 | -41.208 |
| Dividend payment Acquisition of treasury shares Repayment long- and short-term borrowings (-) Proceeds long- and short-term borrowings Net interests paid Other financial expenses |
-11 - -12.301 126.000 -16.336 -324 |
- -13.603 -10.265 - -16.239 -1.100 |
| NET INCREASE IN CASH AND CASH EQUIVALENTS (A+B+C) | 16.009 | -31.719 |
| Effect of exchange rate fluctuations | -606 | -1.003 |
| CASH, CASH EQUIVALENTS AND BANK OVERDRAFTS, CLOSING BALANCE | 72.834 | 80.014 |
| Of which: Cash and cash equivalents Bank overdrafts Cash and cash equivalents related to disposal group held for sale |
68.555 49 4.328 |
80.014 - - |
Key elements:
• Cash flow from operating activities decreased significantly to € -40,5m, driven by low EBIT and an increase in net working capital due to less receivables and stable payables. Inventory build-up in Long Fresh was lower than last year due to the weather conditions and the Listeria impact.
- Cash flow from investing activities amounts to € -40,5m which is higher than last year due to a spill-over effect in CAPEX from previous accounting year and the inclusion of the Mycoculture entities after being acquired.
- Cash flow from financing activities increased in order to finance the operating and investment activities.
CAPEX
Total CAPEX spent reached € 40,2m representing an increase of € 5,5m YoY.
CAPEX in Fresh related to the expansion project in Germany and its ERP system, and investments in a packing machine, equipment and additional ripening capacity in Belgium.
In Long Fresh, CAPEX mainly relates to investments in machinery and equipment, both replacements and new machines (e.g. for preparation of convenience products).
Financial Position
Net financial debt
Net financial debt on 30 September 2018 amounted to € 517,4m (including discontinued operations), which implies an increase of € 98,3m versus March 2018, which is primarily due to a lagging REBITDA performance, Listeria costs, CAPEX payments, deterioration of net working capital and finance charges. As a result, net financial debt/adjusted REBITDA increased to 4,4x from 2,8x per March 2018. Greenyard has taken and continues to take the necessary steps to decrease the net debt and increase profitability over the coming periods. A first decisive step has been made through the sale of the Horticulture segment, which will bring € 120,0m of total cash proceeds before the end of the accounting year.
Working capital
Working capital deteriorated to € -85,3m versus € -152,3m (March 2018). This deterioration is largely driven by a loss of volumes (lower sales) and therefore less receivables (€ -22,8m), resulting in a decrease of our factoring for an amount of € 33,8m. Payables consequently also decreased by € 54,3m. Seasonal inventory build-up amounted to € 35,6m.
Outlook statement
The Board of Directors and management consider that Greenyard continues to be well positioned to deliver profitable growth and to unlock the synergy potential of the business combination going forward.
Subsequent events
Between 30 September 2018 and 20 November 2018 no significant events occurred.
Change in consolidation perimeter
The parent company of Greenyard is Greenyard NV, Sint-Katelijne-Waver, Belgium. The subsidiaries and associates of Greenyard as per 30 September 2018 are the same as presented in the annual report as per 31 March 2018 apart from:
- On 3 April 2018 Greenyard reached an agreement to take over the 49% stake of Ben De Pelsmaeker in Greenyard Fresh Direct Belgium. Greenyard now holds 100% in Greenyard Fresh Direct Belgium. This transaction was mainly (97%) settled in treasury shares.
- On 10 April 2018 Greenyard has acquired a 49% stake in Mor International, whereby it has the option to become majority owner in the future. Currently Mor International is accounted for using the equity method. Mor International is a well-known Israeli fruit sourcing and exporting company strongly focused on sourcing high quality exotics (mangos, avocados, kakis, pomegranates, fresh dates and bell peppers).
Declaration of the statutory auditor
The statutory auditor confirms that the limited review is completed and did not reveal any significant adjustments to the financial information included in the press release.
Financial calendar
| • | Q3 trading update 2018/2019 | 26 February 2019 - before opening market |
|---|---|---|
| • | FY results 2018/2019 | 4 June 2019 - before opening market |
| • | Q1 trading update 2019/2020 | 27 August 2019 - before opening market |
| • | HY results 2019/2020 | 19 November 2019 - before opening market |
For additional information, please contact Greenyard:
Geert Peeters, CFO T.: +32 15 32 42 60 [email protected] Dennis Duinslaeger, Investor Relations T.: +32 15 32 42 49 M.: +32 477 90 39 98 [email protected]
10 / 13
About Greenyard
Greenyard (Euronext Brussels: GREEN) is a global market leader of fresh, frozen and prepared fruit & vegetables, flowers, plants and growing media. Counting Europe's leading retailers amongst its customer base, the group provides efficient and sustainable solutions to customers and suppliers through best-in-class products, market leading innovation, operational excellence and outstanding service.
Our vision is to make lives healthier by helping people enjoy fruit & vegetables at any moment, easy, fast and pleasurable, whilst fostering nature.
With more than 10,000 employees operating in 27 countries worldwide, Greenyard identifies its people and key customer and supplier relationships as the key assets which enable it to deliver goods and services worth more than 4 billion euros per annum.
www.greenyard.group
| Glossary | |
|---|---|
| CAPEX | Capital expenditures |
| EBIT | Operating result |
| EPS | Earnings per share |
| Leverage | NFD/Adjusted REBITDA |
| Net financial debt (NFD) | Interest-bearing debt (at nominal value) less derivatives, bank deposits, cash and cash equivalents |
| Net result | Profit/loss (-) for the period |
| Non-recurring items | Non-recurring items are those that in management's judgement need to be disclosed by virtue of their size or incidence. Such items are disclosed on the face of the consolidated income statement and separately disclosed in the notes to the financial statements. Transactions which may give rise to non-recurring items are principally restructuring and reorganisation activities, impairments, disposal of assets and investments, claims, IFRS 3 acquisition accounting and merger & acquisition projects and the effect of the accelerated repayment of certain financial indebtedness. |
| REBITDA | EBIT corrected for depreciation, amortisation and impairments excluding non-recurring items and EBIT corrected for depreciation, amortisation and impairments from minor divested operations |
| Adjusted REBITDA | Last twelve months REBITDA, adjusted for acquisitions |
| Working capital | Working capital is the sum of the inventories, trade and other receivables (non-current and current) and trade and other payables (current). In this respect trade and other receivables are corrected for long-term (financing) receivables and accrued interest income and trade and other payables exclude accrued interest expenses and dividend payable. |
| AY 18/19 | Accounting year ending 31 March 2019 |
| AY 19/20 | Accounting year ended 31 March 2020 |
| H1 18/19 | First half year of accounting year ending 31 March 2019 |
| H1 19/20 | First half year of accounting year ended 31 March 2020 |
APPENDIX 1: Consolidated income statement
| Consolidated income statement | H1 18/19 | H1 17/18 (*) |
|---|---|---|
| €'000 | €'000 | |
| CONTINUING OPERATIONS | ||
| Sales | 1.982.784 | 2.056.637 |
| Cost of sales | -1.860.790 | -1.911.371 |
| Gross profit/loss (-) | 121.994 | 145.266 |
| Selling, marketing and distribution expenses | -48.884 | -45.971 |
| General and administrative expenses | -66.833 | -64.402 |
| Other operating income | 2.174 | 2.619 |
| Share of profit/loss (-) of equity accounted investments | 182 | 147 |
| EBIT before non-recurring items | 8.633 | 37.658 |
| Non-recurring items from operating activities | -53.041 | -2.076 |
| EBIT | -44.409 | 35.582 |
| Interest expense | -15.844 | -14.330 |
| Interest income | 215 | 218 |
| Other finance result | 351 | -4.344 |
| Net finance income/cost (-) | -15.278 | -18.456 |
| Profit/loss (-) before income tax | -59.687 | 17.126 |
| Income tax expense (-)/income | -8.420 | -6.989 |
| Profit/loss (-) for the period from continuing operations | -68.107 | 10.137 |
| DISCONTINUED OPERATIONS | ||
| Profit/loss (-) for the period from discontinued operations | -44.850 | 2.274 |
| PROFIT/LOSS (-) FOR THE PERIOD | -112.957 | 12.411 |
| Attributable to: | ||
| The shareholders of the Group | -113.378 | 11.688 |
| Non-controlling interests | 421 | 722 |
(*) The consolidated income statement is restated in accordance with IFRS 5 due to the discontinued operation.
REGULATED INFORMATION – INSIDE INFORMATION – 20 NOVEMBER 2018, 17.45 p.m.
APPENDIX 2: Consolidated statement of financial position
| Assets | 30 September 2018 | 31 March 2018 |
|---|---|---|
| €'000 | €'000 | |
| NON-CURRENT ASSETS | 1.173.199 | 1.361.377 |
| Property, plant & equipment | 366.498 | 419.512 |
| Goodwill | 526.765 | 633.852 |
| Other intangible assets | 221.971 | 252.706 |
| Biological assets | 20.883 | 20.711 |
| Investments accounted for using equity method | 11.813 | 9.435 |
| Other financial assets | 29 | 35 |
| Deferred tax assets | 18.586 | 19.630 |
| Trade and other receivables | 6.652 | 5.495 |
| CURRENT ASSETS | 835.305 | 702.245 |
| Biological assets | - | 76 |
| Inventories | 328.666 | 312.393 |
| Trade and other receivables | 291.465 | 331.786 |
| Other financial assets | 1.071 | 558 |
| Cash and cash equivalents | 68.555 | 57.432 |
| Disposal group held for sale | 145.547 | - |
| TOTAL ASSETS | 2.008.503 | 2.063.622 |
| Equity and liabilities | 30 September 2018 | 31 March 2018 |
|---|---|---|
| €'000 | €'000 | |
| EQUITY | 589.063 | 709.218 |
| Issued capital | 288.392 | 288.392 |
| Share premium and other capital instruments | 317.882 | 317.882 |
| Consolidated reserves | -18.794 | 97.316 |
| Cumulative translation adjustments | -9.065 | -7.893 |
| Non-controlling interests | 10.648 | 13.521 |
| NON-CURRENT LIABILITIES | 315.857 | 479.573 |
| Employee benefit liabilities | 20.640 | 21.708 |
| Provisions | 9.902 | 10.940 |
| Interest-bearing loans | 240.249 | 401.034 |
| Other financial liabilities | 569 | 1.341 |
| Trade and other payables | 2.558 | 3.118 |
| Deferred tax liabilities | 41.938 | 41.432 |
| CURRENT LIABILITIES | 1.103.583 | 874.831 |
| Provisions | 4.719 | 8.060 |
| Interest-bearing loans | 335.926 | 59.983 |
| Other financial liabilities | 541 | 2.317 |
| Trade and other payables | 736.849 | 804.470 |
| Liabilities related to disposal group held for sale | 25.547 | - |
| TOTAL EQUITY AND LIABILITIES | 2.008.503 | 2.063.622 |
REGULATED INFORMATION – INSIDE INFORMATION – 20 NOVEMBER 2018, 17.45 p.m.
APPENDIX 3: Reconciliation working capital
| Reconciliation working capital | 30 September 2018 | 31 March 2018 | ||||
|---|---|---|---|---|---|---|
| As reported Reconciliation | Total | As reported Reconciliation | Total | |||
| €'000 | €'000 | €'000 | €'000 | €'000 | €'000 | |
| Inventories | 328.666 | - | 328.666 | 312.393 | - | 312.393 |
| Trade and other receivables (non current/current)(1) |
298.117 | -7.008 | 291.109 | 337.281 | -5.861 | 331.420 |
| Current trade and other payables(2) | -736.849 | 13.361 | -723.488 | -804.470 | 8.345 | -796.125 |
| Continuing operations | -103.713 | -152.311 | ||||
| Inventories | 19.277 | - | 19.277 | |||
| Trade and other receivables (non current/current)(1) |
17.562 | -8 | 17.554 | |||
| Current trade and other payables(2) | -18.496 | 113 | -18.383 | |||
| Discontinued operations | 18.448 | - | ||||
| Working capital | -85.265 | -152.311 |
(1) Long-term (financing) receivables for € 6,4m (AY 17/18 € 5,3m) and accrued interest income for € 0,6m (AY 17/18 € 0,6m) are excluded from the reported working capital.
(2) Accrued interest expenses for € 4,6m (AY 17/18 € 8,3m) are excluded from the reported working capital.
APPENDIX 4: Reconciliation net financial debt
| Reconciliation net financial debt | 30 September 2018 | 31 March 2018 | ||||
|---|---|---|---|---|---|---|
| As reported Reconciliation | Total | As reported Reconciliation | Total | |||
| (*) | (*) | |||||
| €'000 | €'000 | €'000 | €'000 | €'000 | €'000 | |
| Cash and cash equivalents | -68.555 | - | -68.555 | -57.432 | - | -57.432 |
| Interest-bearing loans (non-current/current) | 576.175 | 13.585 | 589.760 | 461.017 | 15.560 | 476.577 |
| Continuing operations | 521.205 | 419.145 | ||||
| Cash and cash equivalents | -4.328 | - | -4.328 | - | - | - |
| Interest-bearing loans (non-current/current) | 558 | - | 558 | - | - | - |
| Discontinued operations | -3.770 | - | ||||
| Net financial debt | 517.435 | 419.145 |
(*) Net capitalised transaction costs related to the refinancing for € 5,4m (AY 17/18 € 6,2m) and net value of the conversion option at inception after amortisation for € 8,2m (AY 17/18 € 9,4m) are added back in order to present the nominal amounts of drawn financing as part of the reported net financial debt.
APPENDIX 5: Reconciliation REBITDA
| EBIT before non-recurring items - REBITDA | H1 18/19 | H1 17/18 |
|---|---|---|
| €'000 | €'000 | |
| EBIT before non-recurring items | 8.633 | 37.658 |
| Depreciation and amortisation | 32.147 | 30.601 |
| Divestitures (not in IFRS 5 scope) | - | 105 |
| Net intercompany transactions between continued and discontinued operations | 391 | 184 |
| REBITDA | 41.171 | 68.549 |
REGULATED INFORMATION – INSIDE INFORMATION – 20 NOVEMBER 2018, 17.45 p.m.